Shobu Y - Search Results

1

The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials.

Schulman G, Berl T, Beck GJ, Remuzzi G, Ritz E, Shimizu M, Shobu Y, Kikuchi M. Schulman G, et al. Among authors: shobu y. BMC Nephrol. 2016 Sep 30;17(1):141. doi: 10.1186/s12882-016-0357-9. BMC Nephrol. 2016. PMID: 27716149 Free PMC article. Clinical Trial.

2

Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120.

Schulman G, Berl T, Beck GJ, Remuzzi G, Ritz E, Shimizu M, Kikuchi M, Shobu Y. Schulman G, et al. Among authors: shobu y. Clin Exp Nephrol. 2018 Apr;22(2):299-308. doi: 10.1007/s10157-017-1447-0. Epub 2017 Jul 24. Clin Exp Nephrol. 2018. PMID: 28741050 Free PMC article. Clinical Trial.

3

Prediction of drug interaction between oral adsorbent AST-120 and concomitant drugs based on the in vitro dissolution and in vivo absorption behavior of the drugs.

Koya Y, Uchida S, Machi Y, Shobu Y, Namiki N, Kotegawa T. Koya Y, et al. Among authors: shobu y. Eur J Clin Pharmacol. 2016 Nov;72(11):1353-1361. doi: 10.1007/s00228-016-2102-5. Epub 2016 Aug 5. Eur J Clin Pharmacol. 2016. PMID: 27491774 Free PMC article.

4

Color Controllable Inorganic Pigments with Ce³⁺ as a Color Source.

Yamaguchi K, Shobu Y, Oka R, Masui T. Yamaguchi K, et al. Among authors: shobu y. Inorg Chem. 2023 Sep 25;62(38):15392-15402. doi: 10.1021/acs.inorgchem.3c01292. Epub 2023 Sep 13. Inorg Chem. 2023. PMID: 37702656

5

Synthesis and Color Evaluation of Ta⁵⁺-Doped Bi₂O₃.

Oka R, Shobu Y, Masui T. Oka R, et al. Among authors: shobu y. ACS Omega. 2019 Apr 25;4(4):7581-7585. doi: 10.1021/acsomega.9b00555. eCollection 2019 Apr 30. ACS Omega. 2019. PMID: 31459851 Free PMC article.

6

Synthesis and characterisation of Ba(Zn_1-x Co _x )₂Si₂O₇ (0 ≤ x ≤ 0.50) for blue-violet inorganic pigments.

Tsukimori T, Shobu Y, Oka R, Masui T. Tsukimori T, et al. Among authors: shobu y. RSC Adv. 2018 Feb 27;8(16):9017-9022. doi: 10.1039/c8ra00101d. eCollection 2018 Feb 23. RSC Adv. 2018. PMID: 35539865 Free PMC article.

7

Hypoxia inhibits JAK2V617F activation via suppression of SHP-2 function in myeloproliferative neoplasm cells.

Mitsumori T, Nozaki Y, Kawashima I, Yamamoto T, Shobu Y, Nakajima K, Morishita S, Komatsu N, Kirito K. Mitsumori T, et al. Among authors: shobu y. Exp Hematol. 2014 Sep;42(9):783-92.e1. doi: 10.1016/j.exphem.2014.05.007. Epub 2014 May 23. Exp Hematol. 2014. PMID: 24860972 Free article. Clinical Trial.

8

[Extramedullary onset of mixed phenotype acute leukemia with MLL gene rearrangement].

Kawashima I, Shobu Y, Yamamoto T, Hamanaka S, Nozaki Y, Nakajima K, Mitsumori T, Kirito K. Kawashima I, et al. Among authors: shobu y. Rinsho Ketsueki. 2013 Mar;54(3):290-4. Rinsho Ketsueki. 2013. PMID: 23676645 Japanese.

9

Rituximab activates Syk and AKT in CD20-positive B cell lymphoma cells dependent on cell membrane cholesterol levels.

Nozaki Y, Mitsumori T, Yamamoto T, Kawashima I, Shobu Y, Hamanaka S, Nakajima K, Komatsu N, Kirito K. Nozaki Y, et al. Among authors: shobu y. Exp Hematol. 2013 Aug;41(8):687-696.e1. doi: 10.1016/j.exphem.2013.04.006. Epub 2013 Apr 17. Exp Hematol. 2013. PMID: 23603515 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters